QA: ARTELO BIOSCIENCES INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2020_ARTELO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001621221')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001621221, ARTELO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 4,442,588
1 IntangibleAssetsNetIncludingGoodwill 2,039,417
2 PropertyPlantAndEquipmentNet 721
3 remainder_Assets 0
4 LiabilitiesCurrent 1,021,513
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 952,334
9 ResearchAndDevelopmentExpense 1,091,992
10 remainder_Expenses 1,165,205
11 remainder_Revenues 0
12 remainder_NetIncome 1,037,355
13 remainder_ComprehensiveNetIncome 2,474
  yvar yval
0 Assets 6,482,726
1 Liabilities 1,021,513
2 Expenses 3,209,531
3 Revenues 0
4 StockholdersEquity 5,461,213
5 NetIncome -2,172,176
6 ComprehensiveNetIncome -2,170,939
7 BaseVar 5,876,800
8 EconomicCapitalRatio 1.92

Edgar->Model Mapping

Feature Distribution

Change over Time